Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
European Journal of Immunology
|
November 9, 2005
On the significance of CD8 alpha alpha expression for T cell memory
Pedro Romero, Jean-Charles Cerottini, Immanuel Luescher
Frontiers in Immunology
|
August 3, 2013
Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes
Julien Schmidt, Danijel Dojcinovic, Philippe Guillaume, et al.
The Journal of Biological Chemistry
|
May 25, 2017
<i>In silico</i> and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopes
Julien Schmidt, Philippe Guillaume, Danijel Dojcinovic, et al.
Haematologica
|
August 10, 2012
MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer
Caroline Poli, Caroline Raffin, Danijel Dojcinovic, et al.
Cytometry
|
July 13, 2002
Use of phycoerythrin and allophycocyanin for fluorescence resonance energy transfer analyzed by flow cytometry: advantages and limitations
Pascal Batard, Janos Szollosi, Immanuel Luescher, et al.
The Journal of Experimental Medicine
|
October 17, 2007
A constant affinity threshold for T cell tolerance
Dieter Naeher, Mark A Daniels, Barbara Hausmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 7, 2010
Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramers
Maha Ayyoub, Danijel Dojcinovic, Pascale Pignon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2010
Assessment of vaccine-induced CD4 T cell responses to the 119-143 immunodominant region of the tumor-specific antigen NY-ESO-1 using DRB1*0101 tetramers
Maha Ayyoub, Pascale Pignon, Danijel Dojcinovic, et al.
Cancer Immunology Research
|
April 26, 2014
Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells
Junko Matsuzaki, Takemasa Tsuji, Immanuel Luescher, et al.
Cancer Research
|
March 27, 2015
Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living Cells
Michael Hebeisen, Julien Schmidt, Philippe Guillaume, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
European Journal of Immunology
|
November 9, 2005
On the significance of CD8 alpha alpha expression for T cell memory
Pedro Romero, Jean-Charles Cerottini, Immanuel Luescher
Frontiers in Immunology
|
August 3, 2013
Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes
Julien Schmidt, Danijel Dojcinovic, Philippe Guillaume, et al.
The Journal of Biological Chemistry
|
May 25, 2017
<i>In silico</i> and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopes
Julien Schmidt, Philippe Guillaume, Danijel Dojcinovic, et al.
Haematologica
|
August 10, 2012
MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer
Caroline Poli, Caroline Raffin, Danijel Dojcinovic, et al.
Cytometry
|
July 13, 2002
Use of phycoerythrin and allophycocyanin for fluorescence resonance energy transfer analyzed by flow cytometry: advantages and limitations
Pascal Batard, Janos Szollosi, Immanuel Luescher, et al.
The Journal of Experimental Medicine
|
October 17, 2007
A constant affinity threshold for T cell tolerance
Dieter Naeher, Mark A Daniels, Barbara Hausmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 7, 2010
Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramers
Maha Ayyoub, Danijel Dojcinovic, Pascale Pignon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 31, 2010
Assessment of vaccine-induced CD4 T cell responses to the 119-143 immunodominant region of the tumor-specific antigen NY-ESO-1 using DRB1*0101 tetramers
Maha Ayyoub, Pascale Pignon, Danijel Dojcinovic, et al.
Cancer Immunology Research
|
April 26, 2014
Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells
Junko Matsuzaki, Takemasa Tsuji, Immanuel Luescher, et al.
Cancer Research
|
March 27, 2015
Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living Cells
Michael Hebeisen, Julien Schmidt, Philippe Guillaume, et al.
Page
of 3